Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Heart risk from headache drug under the microscope

NCT ID NCT04406259

First seen Jan 11, 2026 · Last updated May 22, 2026 · Updated 21 times

Summary

This study looks at a common heart drug, verapamil, which is also used to prevent cluster headaches at much higher doses. Researchers want to see how often it causes a mild heart block (a delay in the heart's electrical signals). The goal is to better understand these side effects so doctors can use the drug more safely. About 60 adults with cluster headaches will take part.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CLUSTER HEADACHE are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • AP-HP Hôpital la Timone

    Marseille, 13005, France

  • CHU de Nice

    Nice, CHUN, 06003, France

Conditions

Explore the condition pages connected to this study.